Susquehanna International Group
IHE icon

Susquehanna International Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Susquehanna International Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,000
Closed -$212K – 13151
2025
Q1 		$212K Buy
+3,000
New +$208K ﹤0.01% 10824
2024
Q3 		– Sell
-6,200
Closed -$411K – 12455
2024
Q2 		$411K Buy
6,200
+800
+15% +$52.4K ﹤0.01% 8733
2024
Q1 		$367K Buy
+5,400
New +$357K ﹤0.01% 9244
2023
Q4 		– Sell
-5,400
Closed -$319K – 12786
2023
Q3 		$319K Sell
5,400
-1,500
-22% -$92K ﹤0.01% 9219
2023
Q2 		$412K Sell
6,900
-300
-4% -$17.8K ﹤0.01% 8767
2023
Q1 		$421K Sell
7,200
-3,300
-31% -$199K ﹤0.01% 8988
2022
Q4 		$651K Buy
10,500
+2,700
+35% +$162K ﹤0.01% 7196
2022
Q3 		$441K Buy
+7,800
New +$480K ﹤0.01% 8820
2021
Q1 		– Sell
-9,900
Closed -$592K – 12503
2020
Q4 		$592K Sell
9,900
-3,300
-25% -$188K ﹤0.01% 7914
2020
Q3 		$720K Sell
13,200
-17,100
-56% -$922K ﹤0.01% 6904
2020
Q2 		$1.55M Buy
30,300
+4,800
+19% +$241K ﹤0.01% 4955
2020
Q1 		$1.14M Buy
25,500
+17,700
+227% +$893K ﹤0.01% 5088
2019
Q4 		$416K Buy
+7,800
New +$384K ﹤0.01% 7342
2019
Q2 		– Sell
-14,700
Closed -$755K – 10507
2019
Q1 		$755K Sell
14,700
-49,500
-77% -$2.46M ﹤0.01% 5538
2018
Q4 		$3.01M Buy
64,200
+600
+0.9% +$30.8K ﹤0.01% 2932
2018
Q3 		$3.56M Sell
63,600
-26,100
-29% -$1.43M ﹤0.01% 3129
2018
Q2 		$4.53M Buy
89,700
+68,400
+321% +$3.39M ﹤0.01% 2839
2018
Q1 		$1.05M Buy
21,300
+10,800
+103% +$554K ﹤0.01% 5134
2017
Q4 		$540K Sell
10,500
-6,000
-36% -$308K ﹤0.01% 6485
2017
Q3 		$860K Buy
+16,500
New +$847K ﹤0.01% 5546

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Susquehanna International Group's IHE Position: Q1 2026 in Review

Susquehanna International Group increased its iShares US Pharmaceuticals ETF (IHE) stake by 2,129% in Q1 2026, buying an estimated $5.05M and bringing the position to 60,401 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4141.

Susquehanna International Group first reported a position in IHE in Q2 2013 and has held it in 50 quarters since. The position peaked at $8.23M in Q2 2023. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Susquehanna International Group held 60,401 shares of iShares US Pharmaceuticals ETF worth $5.24M as of Q1 2026.
  • Susquehanna International Group bought 57,691 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $5.05M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4141 holding.
  • Susquehanna International Group first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 50 quarters since.
  • Susquehanna International Group's iShares US Pharmaceuticals ETF position peaked at $8.23M in Q2 2023.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.